2016
DOI: 10.3389/fpsyt.2016.00091
|View full text |Cite
|
Sign up to set email alerts
|

Trait Impulsivity and Anhedonia: Two Gateways for the Development of Impulse Control Disorders in Parkinson’s Disease?

Abstract: Apathy and impulsivity are two major comorbid syndromes of Parkinson’s disease (PD) that may represent two extremes of a behavioral spectrum modulated by dopamine-dependent processes. PD is characterized by a progressive loss of dopaminergic neurons in the substantia nigra pars compacta to which are attributed the cardinal motor symptoms of the disorder. Dopamine replacement therapy (DRT), used widely to treat these motor symptoms, is often associated with deficits in hedonic processing and motivation, includi… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

1
29
0

Year Published

2018
2018
2023
2023

Publication Types

Select...
9

Relationship

1
8

Authors

Journals

citations
Cited by 32 publications
(30 citation statements)
references
References 189 publications
(245 reference statements)
1
29
0
Order By: Relevance
“…Specifically, anhedonia in our study was positively correlated with PD (rg = 0.8). In fact, anhedonia independent of clinical diagnosis and PD are both dopamine-dependent processes and anhedonia is one of the most commonly observed non-motor symptoms in PD 82 , 83 . Moreover, anhedonia was negatively correlated with nucleus accumbens gray matter volume (rg = −0.6).…”
Section: Discussionmentioning
confidence: 99%
“…Specifically, anhedonia in our study was positively correlated with PD (rg = 0.8). In fact, anhedonia independent of clinical diagnosis and PD are both dopamine-dependent processes and anhedonia is one of the most commonly observed non-motor symptoms in PD 82 , 83 . Moreover, anhedonia was negatively correlated with nucleus accumbens gray matter volume (rg = −0.6).…”
Section: Discussionmentioning
confidence: 99%
“…Indeed, healthy controls have been shown to have levels of ICB equivalent to newly diagnosed Parkinson’s disease patients ( Antonini et al , 2011 ; Weintraub et al , 2013 ). Rather, ICDs in Parkinson’s disease are considered to develop in response to dopamine agonist treatment and interact with underlying Parkinson’s disease pathophysiology and possibly personality traits to manifest as particular behavioural phenotypes ( Weintraub et al , 2013 ; Garcia-Ruiz et al , 2014 ; Sharma et al , 2015 ; Houeto et al , 2016 ; Dawson et al , 2018 ; Baig et al , 2019 ). In particular, ICDs have been associated with the use of non-ergolinic oral dopamine agonists, such as rasagiline, ropinirole and pramipexole ( Garcia-Ruiz et al , 2014 ; Weintraub et al , 2015 ), but also with the use of ergoline-derivatives such as cabergoline ( Weintraub et al , 2010 ), although no straightforward dose-dependent relationship, across individuals, has yet been demonstrated ( Ambermoon et al , 2011 ; Corvol et al , 2018 ; Dawson et al , 2018 ).…”
Section: Introductionmentioning
confidence: 99%
“…Impulse control disorders (ICDs) are a collective term for non-motor symptoms that include pathological gambling, compulsive shopping, hypersexuality, and binge eating ( 1 ). In addition, behavioral disorders such as hobbyism (including pathological internet use), punding, and walkabout have been reported in patients with Parkinson’s disease (PD) ( 2 4 ).…”
Section: Introductionmentioning
confidence: 99%
“…Although several narrative reviews on ICDs related to PD have been published ( 1 , 35 , 36 ), a quantitative meta-analysis that summarizes the existing research could extend earlier reviews by providing overall prevalence estimates (precision estimates) as well as identifying significant moderator variables. Against this backdrop, we conducted a meta-analysis of ICDs in PD aiming to determine the overall prevalence of different ICDs in PD patients in comparison with healthy controls across case–control studies.…”
Section: Introductionmentioning
confidence: 99%